Comparing measures of medication taking in a pharmacotherapy trial for cocaine dependence

Addictive Disorders and their Treatment

Volumn 3, Issue 4, 2004, Pages 165-173

  Mooney, Marc ^a   Sayre, Shelly ^a   Green, Charles ^a   Rhoades, Howard ^a   Schmitz, Joy ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Medication compliance; MEMS; Riboflavin; ROC curve; Self report

Indexed keywords

CARBIDOPA; COCAINE; LEVODOPA; PLACEBO; RIBOFLAVIN; TRACER;

ADULT; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MONITORING; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

EID: 10644225435     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.adt.0000132509.65041.bf     Document Type: Article

References (39)

1. Friedman LM, Furburg CD, DeMets DL. Fundamentals of Clinical Trials. New York: Springer; 1995.
2. Pocock SJ, Abdalla M. The hope and the hazards of using compliance data in randomized controlled trials. Stat Med. 1998;17:303-317.
3. Urquhart J, De Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med. 1998;17:251-267. [discussion 387-389]
4. Rand CS, Weeks K. Measuring adherence with medication regimens in clinical care and research. In: Shumaker SA, ed. The Handbook of Health Behavior Change. New York: Springer Publishing Co.; 1998:114-132.
5. Park LC, Lipman RS. A comparison of patient dosage deviation reports with pill counts. Psychopharmacologia. 1964;6:299-302.
6. Porter AMW. Drug defaulting in general practice. Br Med J. 1969;1:218-222.
7. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clinical Pharmacology & Therapeutics. 1989;46:169-176.
8. Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets? [see comments] Clinical Pharmacology & Therapeutics. 1989;46:163-168.
9. Eisen SA, Woodward RS, Miller D, et al. The effect of medication compliance on the control of hypertension. J Gen Intern Med. 1987;2:298-305.
10. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. [see comments] Arch Intern Med. 1990;150:1509-1510.
11. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074-1090. [discussion 1073]
12. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
13. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32(7-8):749-754.
14. Jay S, DuRant RH, Litt IF, et al. Riboflavin, self-report, and serum norethindrone. Comparison of their use as indicators of adolescent compliance with oral contraceptives. Am J Dis Child. 1984;138:70-73.
15. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
16. Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ. 1995;21:52-57.
17. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. Arch Intern Med. 1979;139:635-638.
18. George CF, Peveler RC, Heiliger S, et al. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000;50:166-171.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, D.C.; 1994.
20. SAS Institute, Inc. Statistical Analysis System [computer program]. Version 8.2. Cary, NC: SAS Institute; 2004.
21. Liu H, Wu T. Estimating the area under a receiver operating characteristic (ROC) curve for repeated measures design. Journal of Statistical Software. 2003;8:1-18.
22. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285-1293.
23. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
24. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. Jan. 1997;50:105-116.
25. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-3277.
26. Straka RJ, Fish JT, Benson SR, et al. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. Jan-Feb. 1997;17:126-132.
27. Del Boca FK, Noll JA. Truth or consequences: the validity of self-report data in health services research on addictions. Addiction. Nov. 2000;95:S347-S360.
28. Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Control Clin Trials. Apr. 2003;24:182-199.
29. Fuller RK, Roth HP. Disulfiram for the treatment of alcoholism. An evaluation in 128 men. Ann Intern Med. Jun. 1979;90:901-904.
30. Kranzler HR, Burleson JA, Korner P, et al. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry. Mar. 1995;152:391-397.
31. Schmitz JM, Stotts AL, Rhoades HM, et al. Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav. 2001;26:167-180.
32. O'Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. Nov. 1992;49:881-887.
33. Del Boca FK, Kranzler HR, Brown J, et al. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res. 1996;20:1412-1417.
34. Cohen P, Cohen J, West SG, et al. Applied Multiple Regression: Correlation Analysis for the Behavioral Sciences. 3rd ed. New York: Lawrence Erlbaum and Associates; 2002.
35. Dirks JF, Kinsman RA. Nondichotomous patterns of medication usage: the yes-no fallacy? Clin Pharmacol Ther. 1982;31:413-417.
36. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657-665.
37. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-2879.
38. Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 2000;58(1-2):9-25.
39. Efron B, Feldman D. Compliance as an explanatory variable in clinical trials? Journal of the American Statistical Association. 1991;86:7-17.